DELTA HEALTH GROUP
*News Flash* The DELTA HEALTH GROUP spotlights its premier, directly managed, multi-specialty, US FDA Phase 2 and Phase 3 clinical trial sites in Asia
SPEARHEADING MEDICAL INNOVATIONS
The DELTA HEALTH GROUP is an international healthcare conglomerate focused on providing a comprehensive portfolio of innovative clinical drug development expertise, a worldwide network of dedicated, premier clinical trial investigative sites and global telemedicine services
ABOUT US
Mission & Vision
Initially starting with the operation of a group of successful clinical trial investigative sites in the United States at the time of embarking on its journey more than two decades back, the DELTA HEALTH GROUP has progressively evolved and diversified its capabilities in clinical drug development and international healthcare.
With a passion for connecting medical innovations to the world of patients, diseases and treatments, we assist partners in the healthcare sector optimize and develop new drugs, biologics and medical devices that aim to offer advanced therapies and an improvement to available patient care.
Overcoming the barriers of distance and resource limitations, our international medical teams of distinguished physicians and surgeons continue to deliver personalized specialist care for patients from assigned geographic regions around the world.
Medical Innovation
Our "A-Team"
Backed by a time-tested, proven track record spanning over 20+ years, the highly talented and experienced best-in-class specialty providers of the DELTA HEALTH "A-Team" have been pioneering medical innovations and have led full clinical development programs that have resulted in successful regulatory approval of a number of prescription drug products from the United States Food and Drug Administration (FDA) and Health Canada. These drugs are being used to treat patients in the United States, Canada and a number of other countries around the world.
The DELTA HEALTH "A Team" takes a pragmatic approach with direct supervision of clinical trials throughout the full duration of the projects. This comprehensive strategy plays a pivotal role in the success of ongoing clinical development programs and differentiates us significantly from leading global competitors.
Expertise In
Late Stage Clinical Development
What Differentiates Us From Others
Over two decades of in-person, face-to-face interactions and successful working collaboration with various Therapeutic Area Divisions of the United States FDA for clinical phase programs related to drugs, biologics and medical devices has significantly enhanced our expertise in the area of late stage clinical development.
This direct engagement with the US FDA has spotlighted us as one of the privileged few in the healthcare industry and provided us an edge over others, with more depth and better understanding for successfully directing FDA clinical development programs for partner companies.
Clinical Trial Investigative Sites
The DELTA HEALTH GROUP operates a global network of dedicated and strategically located Clinical Trial Investigative Sites. These multi-speciality, premier investigative sites, with extensive experience in conducting drug development clinical trials, are managed by the DELTA HEALTH team of highly skilled specialists who have been vetted over time by various therapeutic area Divisions of the United States FDA
Our Unrelenting Commitment To Excellence
Together with our "patient-centric" approach and an unrelenting commitment to excellence, our expertise and ability in running new drug development programs and managing our global clinical trial sites has been championed with deep knowledge and hands-on experience acquired from successfully directing numerous Phase 1 studies and more than 1000 US FDA Phase 2 and Phase 3 clinical trials for drugs, biologics and medical devices.
Our extensive experience with the US FDA gives us the ability to recognize what is required for individual clinical development programs to be successful. One of the main areas of this visibility is in the management of studies conducted under the direct mentorship and supervision of the DELTA HEALTH team at our selected clinical trial investigative sites.
With an acquired acumen for the US FDA clinical drug development process, the DELTA HEALTH team is a reliable partner to co-develop investigational medical products and advance them in the development cycle through final regulatory approval.
Cross-Functional Global Teams
-
The DELTA HEALTH GROUP global teams include dedicated clinical drug development professionals, clinical trial physician investigators, CT site specialists and drug safety experts
-
The clinical development and clinical trial site teams have deep knowledge of legislation and broad based experience of the healthcare industry giving them the flexibility to work in major regions around the world (Go to CLINICAL DEV - CLINICAL TRIAL SITES)
-
The DELTA HEALTH telemedicine division includes U.S. Board Certified Medical and Surgical Specialists, U.K. General Medical Council Specialists and other therapeutic area physicians (Go to INTERNATIONAL TELEMEDICINE)
-
Our Advisory Board includes prestigious names in the world of medicine, including physicians on the faculty of major hospitals and university medical centers in the United States, Canada and the United Kingdom
-
To complement our international medical teams, the DELTA HEALTH GROUP is supported by experts from our Innovative Medical Solutions Division